Halozyme Therapeutics
HALO
#2442
Rank
ยฃ5.64 B
Marketcap
ยฃ47.65
Share price
-1.33%
Change (1 day)
5.70%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): ยฃ0.34 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are ยฃ1.39 Billion. a decrease over its 2024 earnings that were of ยฃ0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 ยฃ0.34 B-16.2%
2024 ยฃ0.41 B59.94%
2023 ยฃ0.25 B39.94%
2022 ยฃ0.18 B0.16%
2021 ยฃ0.18 B92.2%
2020 ยฃ95.53 M-278.96%
2019 -ยฃ53.39 Million-9.45%
2018 -ยฃ58.96 Million-229.51%
2017 ยฃ45.52 M-160.48%
2016 -ยฃ75.27 Million216.03%
2015 -ยฃ23.82 Million-52.86%
2014 -ยฃ50.53 Million-18.09%
2013 -ยฃ61.69 Million55.88%
2012 -ยฃ39.57 Million169.94%
2011 -ยฃ14.66 Million-63.44%
2010 -ยฃ40.09 Million-7.19%
2009 -ยฃ43.2 Million15.91%
2008 -ยฃ37.27 Million83.89%
2007 -ยฃ20.27 Million78.1%
2006 -ยฃ11.38 Million16%
2005 -ยฃ9.81 Million45.24%
2004 -ยฃ6.76 Million682.42%
2003 -ยฃ0.87 Million1659.12%
2002 -ยฃ0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.79 B 7,086.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ7.53 B 2,083.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ19.01 B 5,411.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.68 B 1,549.11%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-ยฃ0.38 Billion-208.17%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
ยฃ22.74 M-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA